The CDMO’s latest investment will boost capacity at its Charles City, IA facility by 40%, underscoring Cambrex’s focus on ...
Wuxi STA, a subsidiary of WuXi AppTec, continued its manufacturing expansion march with the opening of another high-potency active pharmaceutical ingredient (HPAPI) production facility in China. The ...
German CDMO BioSpring is building a new production facility that it hopes will become one of the world's biggest manufacturing sites for DNA- and RNA-based active pharmaceutical ingredients (API). The ...
Anthropic expects to make $3.8 billion selling API access to its models this year, which is double what OpenAI reportedly ...
The Information reports that Anthropic expects to generate as much as $70 billion in revenue and $17 billion in cash flow in ...
Pharmaceutical Technology on MSN
Eli Lilly ramps up orforglipron production with $1.2bn Puerto Rico site expansion
Eli Lilly will invest more than $1.2bn into its manufacturing site in Puerto Rico, as the drugmaker looks to assemble a robust supply chain for oral weight loss pill orforglipron. The funds will be ...
This month, the Joe Biden administration awarded $14 million to the API Innovation Center, a Saint Louis–based nonprofit that aims to remedy supply chain problems for active pharmaceutical ingredients ...
NEW BRIGHTON, Minn.--(BUSINESS WIRE)--APi Group Corporation (NYSE: APG) (“APi” or the “Company”) today announced that it has completed its previously announced acquisition of Elevated Facility ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback